Members of the World Trade Organization passed an amendment allowing poor countries to import generic medications, reports Reuters.
Supply Chain
Kenilworth, N.J.-based Merck will enter into a settlement and licensing agreement with London-based Bristol-Myers Squibb and Japan-based Ono Pharmaceutical Co., following a patent dispute with its blockbuster cancer drug Keytruda, reports Reuters.
President Donald Trump spoke with Rep. Elijah Cummings (D-Md.) at an inaugural luncheon Friday and requested the two meet to discuss the high price of prescription drugs, reports The Hill.
Bioelectronic medicine uses device technology to control cell behavior by analyzing and reproducing electrical signals sent out by the nervous system to the rest of the body.
Ridgemont Equity Partners will acquire the trucking brokerage firm Worldwide Express and combine it with its own trucking unit to create one of the largest third-party logistics providers in the U.S., according to The Wall Street Journal.
Advertisement
Kaleo will provide its Auvi-Q emergency epinephrine auto-injector to many patients at no cost, although the device's list price — which payers will negotiate discounts and rebates from — will be set at $4,500, reports Reuters.
While Mylan agreed to pay $465 million to resolve accusations it improperly classified EpiPens as a generic drug, the Canonsburg, Pa.-based drugmaker has yet to finalize the settlement with the Department of Justice, reports Reuters.
After President Donald Trump said drugmakers were "getting away with murder" during his Jan. 11 press conference, leaders of the pharmaceutical industry responded with varying views.
Researchers at the Feinstein Institute for Medical Research in Manhasset, N.Y., are learning a new language to communicate with the body and redefine treatment of disease and injury — the language of bioelectronic medicine.
After withholding financial support from President-elect Donald Trump during last summer's Republican National Convention, United Parcel Service — along with several other major corporations — contributed to Mr. Trump's inaugural committee, reports The Wall Street Journal.